Bachalli Prithvi S, Nandakumar H, Srinath N
Consultant Oral and Maxillofacial Surgeon, Krishnadevaraya College of Dental Sciences and Hospital, Bangalore, India ; Consultant Oral and Maxillofacial Surgeon Vasuki, #1123, 19th Main, 2nd Phase, J.P.Nagar, Bangalore, 560078 India.
J Maxillofac Oral Surg. 2009 Jun;8(2):167-72. doi: 10.1007/s12663-009-0041-8. Epub 2009 Aug 11.
The objectives of this study was to evaluate subjectively the analgesic efficacy of Oral Diclofenac Sodium against Diclofenac Sodium Transdermal patch in the management of postoperative pain following surgical removal of impacted mandibular third molars.
Twenty healthy subjects belonging to both the sexes in the age group of 18-40 years with bilateral mesioangular impactions of mandibular third molar teeth underwent surgical removal under local anaesthesia by administering an inferior alveolar nerve block on two different occasions with a minimum interval of 1 week in-between the procedures. The postoperative pain was recorded on visual analog scale, a verbal rating scale, a pain relief scale and a pain intensity scale. Readings were taken at 2 hours, 4 hours, 8 hours, 12 hours and 24 hours postoperatively, taking the time at which the surgery was completed as a reference. On the second and third days, the repeat medication was administered at that reference time and recordings taken at the same intervals for a total of 3 days. Patients received the study medication i.e. Diclofenac Sodium 100mg once a day for 3 days after performing surgery on one side and the same patients were given Diclofenac Sodium Transdermal Patch 100mg once a day for 3 days after performing surgery on the contralateral side.
Both the statistical analysis and clinical observation showed that on the first postoperative day diclofenac sodium administered orally has slightly more significant efficacy when compared to the drug administered transdermally. However, on the second and third postoperative days there was no statistical or clinical difference in the pain control by either route of administration.
The study concludes that transdermal diclofenac sodium can be used as an alternative form of pain control following removal of impacted mandibular third molars, however considering that the analgesic potency might be lesser in the immediate postoperative period, it might be prudent to use oral diclofenac sodium for immediate postoperative pain relief, following which transdermal route can be used for pain control.
本研究的目的是主观评估口服双氯芬酸钠与双氯芬酸钠透皮贴剂在拔除下颌阻生第三磨牙术后疼痛管理中的镇痛效果。
20名年龄在18 - 40岁的健康受试者,双侧下颌第三磨牙均为近中阻生,在局部麻醉下接受手术拔除,通过在下牙槽神经阻滞下分两次进行手术,两次手术间隔至少1周。术后疼痛采用视觉模拟评分、语言评定量表、疼痛缓解量表和疼痛强度量表进行记录。以手术完成时间为参考,在术后2小时、4小时、8小时、12小时和24小时进行读数。在术后第二天和第三天,在该参考时间重复给药,并在相同间隔进行记录,共记录3天。患者在一侧手术后每天服用一次研究药物即100mg双氯芬酸钠,共3天,同一患者在对侧手术后每天使用一次100mg双氯芬酸钠透皮贴剂,共3天。
统计分析和临床观察均表明,术后第一天口服双氯芬酸钠的疗效比经皮给药的药物略显著。然而,在术后第二天和第三天,两种给药途径在疼痛控制方面没有统计学或临床差异。
该研究得出结论,透皮双氯芬酸钠可作为拔除下颌阻生第三磨牙后疼痛控制的替代形式,然而考虑到术后即刻镇痛效力可能较低,术后即刻使用口服双氯芬酸钠缓解疼痛可能更为谨慎,之后可采用透皮途径进行疼痛控制。